These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10636730)

  • 1. Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa.
    Pulkkinen L; Marinkovich MP; Tran HT; Lin L; Herron GS; Uitto J
    J Invest Dermatol; 1999 Dec; 113(6):1114-8. PubMed ID: 10636730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa.
    Darling TN; McGrath JA; Yee C; Gatalica B; Hametner R; Bauer JW; Pohla-Gubo G; Christiano AM; Uitto J; Hintner H; Yancey KB
    J Invest Dermatol; 1997 Apr; 108(4):463-8. PubMed ID: 9077475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa.
    Darling TN; Yee C; Koh B; McGrath JA; Bauer JW; Uitto J; Hintner H; Yancey KB
    J Invest Dermatol; 1998 Feb; 110(2):165-9. PubMed ID: 9457913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.
    Shimizu H; Takizawa Y; Pulkkinen L; Zone JJ; Matsumoto K; Saida T; Uitto J; Nishikawa T
    J Invest Dermatol; 1998 Nov; 111(5):887-92. PubMed ID: 9804354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.
    Jonkman MF; de Jong MC; Heeres K; Pas HH; van der Meer JB; Owaribe K; Martinez de Velasco AM; Niessen CM; Sonnenberg A
    J Clin Invest; 1995 Mar; 95(3):1345-52. PubMed ID: 7883981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A founder COL17A1 splice site mutation leading to generalized atrophic benign epidermolysis bullosa in an extended inbred Palestinian family from Israel.
    Whittock NV; Sher C; Gold I; Libman V; Reish O
    Genet Med; 2003; 5(6):435-9. PubMed ID: 14614394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa.
    McGrath JA; Gatalica B; Christiano AM; Li K; Owaribe K; McMillan JR; Eady RA; Uitto J
    Nat Genet; 1995 Sep; 11(1):83-6. PubMed ID: 7550320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency.
    Jonkman MF; de Jong MC; Heeres K; Steijlen PM; Owaribe K; Küster W; Meurer M; Gedde-Dahl T; Sonnenberg A; Bruckner-Tuderman L
    Arch Dermatol; 1996 Feb; 132(2):145-50. PubMed ID: 8629821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa.
    Pohla-Gubo G; Lazarova Z; Giudice GJ; Liebert M; Grassegger A; Hintner H; Yancey KB
    Exp Dermatol; 1995 Aug; 4(4 Pt 1):199-206. PubMed ID: 8535614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.
    Huber M; Floeth M; Borradori L; Schäcke H; Rugg EL; Lane EB; Frenk E; Hohl D; Bruckner-Tuderman L
    J Invest Dermatol; 2002 Jan; 118(1):185-92. PubMed ID: 11851893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Academy of Dermatology 1997 Awards for Young Investigators in Dermatology. Mutational analysis of the bullous pemphigoid antigen 2/type XVII collagen gene in patients with generalized atrophic benign epidermolysis bullosa.
    Darling TN
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):773-4. PubMed ID: 9366826
    [No Abstract]   [Full Text] [Related]  

  • 12. A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa.
    McGrath JA; Darling T; Gatalica B; Pohla-Gubo G; Hintner H; Christiano AM; Yancey K; Uitto J
    J Invest Dermatol; 1996 Apr; 106(4):771-4. PubMed ID: 8618019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.
    Floeth M; Bruckner-Tuderman L
    Am J Hum Genet; 1999 Dec; 65(6):1530-7. PubMed ID: 10577906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion--reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes.
    Borradori L; Chavanas S; Schaapveld RQ; Gagnoux-Palacios L; Calafat J; Meneguzzi G; Sonnenberg A
    Exp Cell Res; 1998 Mar; 239(2):463-76. PubMed ID: 9521865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa.
    Chavanas S; Gache Y; Tadini G; Pulkkinen L; Uitto J; Ortonne JP; Meneguzzi G
    J Invest Dermatol; 1997 Jul; 109(1):74-8. PubMed ID: 9204958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound heterozygosity for a point mutation and a deletion located at splice acceptor sites in the LAMB3 gene leads to generalized atrophic benign epidermolysis bullosa.
    Takizawa Y; Hiraoka Y; Takahashi H; Ishiko A; Yasuraoka I; Hashimoto I; Aiso S; Nishikawa T; Shimizu H
    J Invest Dermatol; 2000 Aug; 115(2):312-6. PubMed ID: 10951252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families.
    Nakano A; Lestringant GG; Paperna T; Bergman R; Gershoni R; Frossard P; Kanaan M; Meneguzzi G; Richard G; Pfendner E; Uitto J; Pulkkinen L; Sprecher E
    J Am Acad Dermatol; 2002 Apr; 46(4):510-6. PubMed ID: 11907499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of gene expression profiles in keratinocytes from patients with generalized atrophic benign epidermolysis bullosa.
    Huber A; Yee C; Darling TN; Yancey KB
    Exp Dermatol; 2002 Feb; 11(1):75-81. PubMed ID: 11952829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation.
    Darling TN; Yee C; Bauer JW; Hintner H; Yancey KB
    J Clin Invest; 1999 May; 103(10):1371-7. PubMed ID: 10330419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel homozygous and compound heterozygous COL17A1 mutations associated with junctional epidermolysis bullosa.
    Floeth M; Fiedorowicz J; Schäcke H; Hammami-Hausli N; Owaribe K; Trüeb RM; Bruckner-Tuderman L
    J Invest Dermatol; 1998 Sep; 111(3):528-33. PubMed ID: 9740252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.